QSAM Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Common Stock, Preferred Stock and Warrants (Tables)

Common Stock, Preferred Stock and Warrants (Tables)

3 Months Ended

Mar. 31, 2017

Summary of All Outstanding Common Stock Warrants

The following is a summary of all outstanding common stock warrants as of March 31, 2017:

	Number of Warrants		Exercise price per share		Average remaining term in years		Aggregate fair value
Warrants issued in connection with issuance of Debentures		415,000	$	0.50		2.25	$	23,686
Warrants issued in connection with issuance of Preferred Stock		1,153,845	$	0.50		3.60	$	60,878

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details